RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Brandenburg Kapital
B

Brandenburg Kapital portfolio

Brandenburg Kapital has 1 portfolio company on record at Recent Funding.

Type: Venture capital.
Portfolio on Recent Funding: 1.
Deals, last 12 months: 0.
Rounds led: 1 of 1.
Capital in their rounds: $7.77M.
Latest deal: 4TEEN4 Pharmaceuticals · Dec 5, 2019.
About this page

It is a venture capital firm based in Potsdam, DE, founded in 1993. Its most recent investment on record is 4TEEN4 Pharmaceuticals's $7.77M Series A round in December 2019, which it led. That company is in Health and bio.

About Brandenburg Kapital

Firm type: Venture capital.
Headquarters: Potsdam, DE.
Founded: 1993.
Stages: Seed, Series A, Growth.
Sectors: AgTech, AI & Machine Learning, Biotech, Cleantech, Deep Tech, Digital Health, Energy, Enterprise Software, Hardware, Healthtech, IoT, Medical Devices, Mobility & Transportation, Robotics, SaaS, Sector Agnostic.
Check size: $108K to $5.4M.
Leads rounds: Yes.
Portfolio companies: 107.
Exits: 0.
Rounds led: 0.

What Brandenburg Kapital invests in

How Brandenburg Kapital invests

StageDealsCapital in rounds
Series A 1 100%$7.77M

Brandenburg Kapital portfolio companies

CompanyRound with Brandenburg KapitalTotal raisedLatest raise
44TEEN4 Pharmaceuticals
Health and bio
Series A · $7.77M · lead$7.77MNov 13, 2025
Series B+

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Firm profile: Fundraising Fox Open Dataset v2026-11, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.

Share is of the 1 round on Recent Funding that name Brandenburg Kapital. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists Brandenburg Kapital, which is a subset of its real portfolio. API: /api/v1/investors/brandenburg-kapital (get a free API key). More: the most active VC firms and new venture capital funds.